Informing patients about tardive dyskinesia

Area of Science:

• Psychiatry
• Clinical Psychology
• Neuroscience

Background:

• Informed consent is crucial for neuroleptic treatment in schizophrenia.
• Tardive dyskinesia is a potential side effect of neuroleptic medications.
• Assessing patient understanding of treatment information is essential.

Purpose of the Study:

• To compare the effectiveness of formal (written) versus informal (oral) methods for obtaining informed consent for neuroleptic treatment.
• To evaluate knowledge acquisition and retention regarding neuroleptic treatment and tardive dyskinesia.
• To assess the impact of informed consent methods on treatment compliance and relapse rates.

Main Methods:

• A comparative study involving 25 schizophrenic outpatients with tardive dyskinesia.
• Informed consent was obtained using either a formal written approach or an informal oral presentation.
• Knowledge assessment was conducted immediately after consent and at a two-month follow-up.

Main Results:

• Both groups showed significant knowledge increases, but only the informal/oral group retained knowledge at follow-up.
• Patients generally did not learn information critical for rational decision-making about neuroleptic treatment.
• Younger patients demonstrated better baseline knowledge and retention.
• No increase in relapse or noncompliance was observed compared to a control group.

Conclusions:

• Informal, repeated oral disclosure of information about neuroleptic treatment and tardive dyskinesia is more effective for knowledge retention in schizophrenic outpatients.
• Disclosure of tardive dyskinesia information is safe and can be integrated into the therapeutic relationship.
• While knowledge acquisition is important, its retention and application for decision-making require further optimization.